By comparing our data with real-world genetics and proteomics, we have shown that the abundance of many of the top-ranked proteins changed by semaglutide are implicated across a range of biological processes underlying BMI and T2D, from body weight regulation to glycemic control, to lipid metabolism, inflammatory pathways, immune function, adipose tissue function and several other obesity-related complications
At 5,000 mcg/mL that is 0.4 mL, which equals 40 units on a U-100 syringe
In research it is studied for melanocortin pathway pharmacology, central appetite regulation, and pigmentation signaling
Researchers are already testing triple-agonist drugs, such as retatrutide, which target GLP-1, GIP and glucagon receptors